Utah Medical Products (UTMD) Common Equity (2010 - 2026)
Utah Medical Products (UTMD) posted quarterly Common Equity of $120.4 million for Q1 2026, up 2.84% year-over-year from $117.0 million in Q1 2025, and up 0.93% quarter-over-quarter from $119.3 million in Q4 2025.
Utah Medical Products (UTMD) Common Equity (2010 - 2026) Analysis & Trends
Utah Medical Products' Common Equity history runs 17 years deep, the most recent figure standing at $120.4 million for Q1 2026.
- In Q1 2026, Common Equity rose 2.84% year-over-year to $120.4 million; the TTM figure through Mar 2026 stood at $120.4 million (up 2.84% YoY), while the FY2025 annual figure was $119.3 million, up 1.57% from the prior year.
- Common Equity for Q1 2026 stood at $120.4 million, up from $119.3 million in the prior quarter.
- The five-year high for Common Equity was $128.3 million in Q4 2023, with the low at $107.5 million in Q2 2022.
- The 5-year median for Common Equity is $118.3 million (2025), against an average of $118.6 million.
- The sharpest annual moves came in 2023 and 2024: Common Equity advanced 14.34% in 2023, then declined 8.48% in 2024.
- Utah Medical Products' Common Equity stood at $114.3 million in 2022, then advanced by 12.3% to $128.3 million in 2023, then slipped by 8.48% to $117.4 million in 2024, then gained by 1.57% to $119.3 million in 2025, then climbed by 0.93% to $120.4 million in 2026.
- Business Quant data shows UTMD's Common Equity at $120.4 million in Q1 2026, $119.3 million in Q4 2025, and $118.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.53 Bn | 129.32 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.71 Bn | 34.36 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.80 Bn | 32.33 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.08 Bn | 26.40 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 24.97 Bn | 24.53 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.82 Bn | 14.68 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.60 Bn | 11.45 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Utah Medical Products | 226.76 Mn | 139.24 Mn | 4.76 Mn | 122.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 122.03 Mn |
| Mar 31, 2026 | 120.37 Mn |
| Dec 31, 2025 | 119.27 Mn |
| Sep 30, 2025 | 118.25 Mn |
| Jun 30, 2025 | 117.53 Mn |
| Mar 31, 2025 | 117.05 Mn |
| Dec 31, 2024 | 117.43 Mn |
| Sep 30, 2024 | 124.20 Mn |
| Jun 30, 2024 | 124.05 Mn |
| Mar 31, 2024 | 127.74 Mn |
| Dec 31, 2023 | 128.31 Mn |
| Sep 30, 2023 | 123.70 Mn |
| Jun 30, 2023 | 121.76 Mn |
| Mar 31, 2023 | 118.02 Mn |
| Dec 31, 2022 | 114.26 Mn |
| Sep 30, 2022 | 108.19 Mn |
| Jun 30, 2022 | 107.47 Mn |
| Mar 31, 2022 | 109.17 Mn |
| Dec 31, 2021 | 107.14 Mn |
| Sep 30, 2021 | 109.98 Mn |